EX-76545

N/A

Report date: 2023/01/08 22:49:54
NME

Base Information

Drug NameEX-76545
Drug Alias NameEX-76545
ClassificationSmall molecules
Mechanisms of ActionTyrosine-protein kinase JAK1 inhibitorsTyrosine-protein kinase JAK2 inhibitors
TargetsTyrosine-protein kinase JAK1Tyrosine-protein kinase JAK2
Therapy Area/IndicationsLiver Cirrhosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBoehringer Ingelheim Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesBoehringer Ingelheim Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsLiver Cirrhosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A